Nasdaq:US$15.34 (-0.14) | HKEX:HK$23.90 (-0.30) | AIM:£2.21 (-0.05)
News & Presentations
Previous Article   |   Next Article
Presentations | 6 Jun 2022

ASCO2022: Surufatinib in US Patients with Soft Tissue Sarcoma